======= C5orf45 ======= == Gene Information == * **Official Symbol**: MRNIP * **Official Name**: MRN complex interacting protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51149|51149]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6NTE8|Q6NTE8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C5orf45&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C5orf45|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617154|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in the cellular response to DNA damage and the maintenance of genome stability through its association with the MRN damage-sensing complex (PubMed:27568553). Promotes chromatin loading and activity of the MRN complex to facilitate subsequent ATM-mediated DNA damage response signaling and DNA repair (PubMed:27568553). No Pfam Domain information is available for this gene. |Mre11 complex| |positive regulation of double-strand break repair via homologous recombination| |mitotic G2 DNA damage checkpoint| |protein localization to chromatin| |regulation of double-strand break repair via nonhomologous end joining| |mitotic G2/M transition checkpoint| |G2 DNA damage checkpoint| |positive regulation of double-strand break repair| |positive regulation of DNA recombination| |regulation of double-strand break repair via homologous recombination| |protein localization to chromosome| |positive regulation of DNA repair| |regulation of double-strand break repair| |negative regulation of G2/M transition of mitotic cell cycle| |mitotic DNA damage checkpoint| |positive regulation of response to DNA damage stimulus| |negative regulation of cell cycle G2/M phase transition| |regulation of DNA recombination| |mitotic DNA integrity checkpoint| |regulation of DNA repair| |DNA damage checkpoint| |DNA integrity checkpoint| |response to ionizing radiation| |mitotic cell cycle checkpoint| |positive regulation of DNA metabolic process| |cell cycle checkpoint| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |regulation of response to DNA damage stimulus| |negative regulation of cell cycle phase transition| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |regulation of DNA metabolic process| |chromatin binding| |regulation of mitotic cell cycle phase transition| |response to radiation| |regulation of cell cycle phase transition| |DNA repair| |positive regulation of protein kinase activity| |negative regulation of cell cycle| |positive regulation of kinase activity| |mitotic cell cycle process| |regulation of mitotic cell cycle| |positive regulation of transferase activity| |mitotic cell cycle| |protein localization to organelle| |regulation of cellular response to stress| |DNA metabolic process| |regulation of cell cycle process| |cellular response to DNA damage stimulus| |regulation of protein kinase activity| |regulation of kinase activity| |regulation of transferase activity| |cell cycle process| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |response to abiotic stimulus| |regulation of cell cycle| |positive regulation of protein modification process| |cell cycle| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of response to stress| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp111|R-DABN 8μM R03 exp111]]|-2.12| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17781 * **Expression level (log2 read counts)**: 5.95 {{:chemogenomics:nalm6 dist.png?nolink |}}